Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free ALPMY Stock Alerts $9.90 -0.09 (-0.90%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Astellas Pharma Short Interest DataCurrent Short Interest74,100 sharesPrevious Short Interest83,900 sharesChange Vs. Previous Month-11.68%Dollar Volume Sold Short$726,180.00Short Interest Ratio0.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,809,660,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume524,696 sharesAverage Trading Volume297,921 sharesToday's Volume Vs. Average176% Short Selling Astellas Pharma ? Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPMY Short Interest Over TimeALPMY Days to Cover Over TimeALPMY Percentage of Float Shorted Over Time Ad American AlternativeYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW Astellas Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202474,100 shares $726,180.00 -11.7%N/A0.1 $9.80 4/30/202483,900 shares $801,245.00 +20.2%N/A0.1 $9.55 4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27 3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75 3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83 2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05 1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08 12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90 12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36 11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16 11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65 10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69 10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04 9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85 9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91 8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14 8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13 7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63 7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40 6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87 6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12 5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77 5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03 4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02 4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81 3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20 3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77 2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00 2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37 1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68 1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62 12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16 12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57 11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46 11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07 10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86 10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33 9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33 9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77You won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30 7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57 7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82 6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56 6/15/202239,200 shares $587,216.00 +1,087.9%N/A0.2 $14.98 5/31/20223,300 shares $52,503.00 -85.3%N/A0 $15.91 5/15/202222,400 shares $339,360.00 -62.5%N/A0.1 $15.15 4/30/202259,700 shares $905,649.00 +69.1%N/A0.3 $15.17 4/15/202235,300 shares $580,685.00 +451.6%N/A0.2 $16.45 3/31/20226,400 shares $99,712.00 +220.0%N/A0 $15.58 3/15/20222,000 shares $31,320.00 -75.3%N/A0 $15.66 2/28/20228,100 shares $135,108.00 -77.7%N/A0 $16.68 2/15/202236,300 shares $627,046.20 -17.7%N/A0.2 $17.27 1/31/202244,100 shares $712,215.00 -4.8%N/A0.2 $16.15 1/15/202246,300 shares $764,413.00 +282.6%N/A0.3 $16.51 12/31/202112,100 shares $196,867.00 -55.4%N/A0.1 $16.27 12/15/202127,100 shares $431,161.00 -13.1%N/A0.1 $15.91 11/30/202131,200 shares $485,316.00 -50.9%N/A0.2 $15.56 11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37 10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88 10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55 9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52 9/15/202137,000 shares $629,000.00 +380.5%N/A0.4 $17.00 8/31/20217,700 shares $129,206.00 +3,750.0%N/A0.1 $16.78 8/13/2021200 shares $3,246.00 -97.2%N/A0 $16.23 7/30/20217,200 shares $114,624.00 -36.8%N/A0.1 $15.92 7/15/202111,400 shares $198,474.00 -81.7%N/A0.1 $17.41 6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38 6/15/202151,600 shares $904,548.00 -28.3%N/A0.3 $17.53 5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22 5/14/202114,100 shares $215,166.00 +1,914.3%N/A0.1 $15.26 4/30/2021700 shares $10,461.50 -82.1%N/A0 $14.95 4/15/20213,900 shares $58,812.00 -76.4%N/A0 $15.08 3/31/202116,500 shares $258,060.00 +66.7%N/A0.2 $15.64 3/15/20219,900 shares $164,835.00 -73.9%N/A0.1 $16.65 2/26/202137,900 shares $626,108.00 -41.4%N/A0.5 $16.52 2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99 1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38 1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91 12/31/202017,600 shares $271,040.00 -56.4%N/A0.1 $15.40 12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59 11/30/202061,200 shares $954,108.00 +367.2%N/A0.5 $15.59 11/15/202013,100 shares $203,312.00 +718.8%N/A0.1 $15.52 10/30/20201,600 shares $22,256.00 -88.8%N/A0 $13.91 10/15/202014,300 shares $202,488.00 +44.4%N/A0.1 $14.16 9/30/20209,900 shares $147,609.00 +125.0%N/A0.1 $14.91 9/15/20204,400 shares $67,056.00 -91.3%N/A0 $15.24 8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67 8/14/20206,500 shares $106,340.00 -59.4%N/A0.1 $16.36 7/31/202016,000 shares $251,168.00 +742.1%N/A0.1 $15.70Obama’s Forever Term [exposed] (Ad)Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here 7/15/20201,900 shares $31,027.00 -96.6%N/A0 $16.33 6/30/202056,000 shares $932,960.00 +266.0%N/A0.6 $16.66 6/15/202015,300 shares $251,945.10 +393.6%N/A0.1 $16.47 5/29/20203,100 shares $55,304.00 -35.4%N/A0 $17.84 5/15/20204,800 shares $76,800.00 -66.0%N/A0.1 $16.00 4/30/202014,100 shares $230,535.00 +65.9%N/A0.1 $16.35 4/15/20208,500 shares $138,805.00 +7.6%N/A0.1 $16.33 3/31/20207,900 shares $129,165.00 -92.7%N/A0 $16.35 3/13/2020107,900 shares $1.67 million +233.0%N/A0.7 $15.52 2/28/202032,400 shares $427,032.00 -20.6%N/A0.4 $13.18 2/14/202040,800 shares $641,376.00 +164.9%N/A0.5 $15.72 1/31/202015,400 shares $249,172.00 -32.5%N/A0.3 $16.18 1/15/202022,800 shares $418,608.00 -30.3%N/A0.3 $18.36 12/31/201932,700 shares $569,307.00 +1,621.1%N/A0.5 $17.41 ALPMY Short Interest - Frequently Asked Questions What is Astellas Pharma's current short interest? Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 74,100 shares of ALPMY short. Learn More on Astellas Pharma's current short interest. Is Astellas Pharma's short interest increasing or decreasing? Astellas Pharma saw a decrease in short interest in May. As of May 15th, there was short interest totaling 74,100 shares, a decrease of 11.7% from the previous total of 83,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Astellas Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Astellas Pharma: Teva Pharmaceutical Industries Limited (1.16%), BeiGene, Ltd. (1.75%), Alnylam Pharmaceuticals, Inc. (2.01%), Genmab A/S (0.45%), BioMarin Pharmaceutical Inc. (1.97%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Sarepta Therapeutics, Inc. (6.94%), Merck KGaA (0.37%), Dr. Reddy's Laboratories Limited (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Astellas Pharma stock? Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astellas Pharma? A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further. How often is Astellas Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TEVA Short Interest BGNE Short Interest ALNY Short Interest GMAB Short Interest BMRN Short Interest VTRS Short Interest UTHR Short Interest SRPT Short Interest MKGAF Short Interest RDY Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ALPMY) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeHe Is Giving Away BitcoinCrypto Swap ProfitsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.